Publications

Scholarly Journals--Submitted

  • Almaguel FA, Sanchez TW, Ortiz-Hernandez GL, Casiano CA (2020) Alpha-enolase: emerging tumor associated antigen, cancer biomarker, and oncotherapeutic target.  (submitted to Frontiers in Genetics) (10/2020)
  • Martinez SR, Elix C, Sanchez-Hernandez ES, Ortiz-Hernandez GL, Zhang L, and Casiano CA (2020). Glucocorticoid receptor-beta catenin interaction supports prostate cancer chemoresistance.  Endocrine Related Cancer (in revision) (08/2020)

Scholarly Journals--Published

  • Malika N, Ogundimu O, Roberts L, Alemi Q, Casiano CA, Montgomery S (2020) African Immigrant Health: Prostate Cancer Attitudes and Perceptions.  American J. Men’s Health  (08/2020)
  • Infantino M, Carbone T, Manfredi M, Grossi V, Benuci M, Casiano CA, Bizzaro N (2020). Dense fine speckled (DFS) immunofluorescence pattern and anti-DFS70 antibodies: cleaning up the current concepts.  Clinica Chimica Acta 510:157-159   (07/2020)
  • Montero M, Liu J-W, Orozco J, Casiano CA, De Leon M (2020). Neuroprotective Effects of Docosahexanoic Acid from Lipotoxicity Stress Injury Involve Enhancement of Autophagy and Inhibition of Apoptosis.  J. Neurochemistry (online ahead of print) (05/2020)
  • Ortiz-Hernandez GL, Sanchez-Hernandez ES, Casiano CA (2020). Twenty years of research on the DFS70/LEDGF autoantibody-autoantigen system: many lessons learned but still many questions.  AutoImmunity Highlights 11(1):3, pp 1-19 (02/2020)
  • Sanchez TW, Li B, Molinaro C, Casiano CA, Bellinger DL, Mata-Greenwood E (2020). Maternal plasma proteomics in a rat model of pregnancy complications reveal immune and pro-coagulant gene pathway activation.  American Journal of Reproductive Immunology; 83(2):e13205.  (02/2020)
  • Mahler M, Andrade LE, Casiano CA, Malyavantham K, Fritzler MJ (2019). Implications for redefining  the dense fine speckled and related immunofluorescence patterns.  Expert Rev Clin Immunol;15(5):447-448.  (05/2019)
  • Mahler M, Andrade LE, Casiano CA, Malyavantham K, Fritzler MJ (2019) Anti-DFS70 antibodies; an update on our current understanding and their clinical usefulness.  Expert Rev Clin Immunol 15(3):241-250. (03/2019)
  • Roberts LR, Wilson CM, Casiano CA, Stiel L, and Montgomery S (2018).  Prostate Cancer Screening Among High-Risk Black Men. J. Nurse Practitioners 14:677-682. (10/2018)
  • Woods-Burnham L, Cajigas-Du Ross CK, Love A, Basu A, Sanchez-Hernandez ES, Martinez SR, Ortiz-Hernández GL, Stiel L, Durán AM, Wilson C, Montgomery S, Roy S, and Casiano CA (2018). Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells. Scientific Reports 8:15063. (10/2018)
  • Gardner SA, Salto LM, Riggs ML, Casiano CA, and De Leon M (2018) Supporting the Writing Productivity of Biomedical Graduate Students: Creating a Community of Science Writers. CBE Life Sci Education 17:ar45. (09/2018)
  • Cajigas-Du Ross C, Martinez SR, Woods-Burnham L, Duran AM, Roy S, Basu A, Ramirez JA, Ortiz-Hernandez GL, Rios-Colon L, Chirsev E, Sanchez-Hernandez ES, Soto U, Greco C, Boucheix C, Chen X, Unternaehrer J, Wang C, and Casiano CA (2018). RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance.  Oncotarget 9:30363-30384.  (07/2018)
  • Woods-Burnham L, Basu A, Cajigas-Du Ross CK, Love A, Yates C, De Leon M, Roy S, and Casiano CA (2017). The 22RV1 prostate cancer cell line carries mixed genetic ancestry: implications for prostate cancer health disparities research using pre-clinical models.  Prostate 77:1601-1608.    (12/2017)
  • Vázquez-Del Mercado M, Gómez-Bañuelos E, Navarro-Hernández RE, Pizano-Martinez O, Chavarria-Avila E, Andrade-Ortega L, Saavedra MA, Jara LJ, Medrano-Ramírez G, Enriconi-Dos Anjos L, Basu A, Albesa R, Mahler M, and Casiano CA (2017). Detection of Autoantibodies to DSF70/LEDGFp75 in Mexican Hispanics Using Multiple Complementary Assay Platforms. AutoImmunity Highlights 8(1):1 (12/2017)
  • Khan S, Simpson J, Turay D, Mirshahidi S, Gonda A, Sanchez TW, Casiano CA*, and Wall NR (2017). Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in exosomes from prostate cancer patients.  PLoS One12(10):e0183122 *shared senior authorship    (10/2017)
  • Rios-Colon L, Cajigas-Du Ross C, Basu A, Elix C, Alicea-Polanco I, Sanchez TW, Radhakrisnan V, Chen CS, and Casiano CA (2017).  Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.  Oncotarget 8(15):24915-24931.    (04/2017)
  • Sanchez TW, Zhang G, Dai L, Li J, Mirshahidi S, Wall NR, Wilson C, Yates C, Montgomery S, Zhang JY, and Casiano CA(2016) Immunoproteomic profiling of autoantibodies in African American men with prostate cancer: evidence for an autoantibody response to glycolysis and plasminogen-associated proteins. Molecular and Cellular Proteomics 15:3564-80.    (12/2016)
  • Dai L, Li J, Lei N, Xing M, Sanchez TW, Casiano CA*, and Zhang JY (2016).  Using serological proteomics analysis to identify anti-nucleophosmin 1 autoantibody in sera from European American and African American prostate cancer patients as potential biomarker.  Prostate 76:1375-86. *shared senior authorship      (11/2016)
  • Ochs RL, Mahler M, Basu A, Rios-Colon L, Sanchez TW, Andrade LE, Fritzler MJ, and Casiano CA (2016) The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.  Clinical and Experimental Medicine 16:273-93.    (08/2016)
  • Li J, Dai L, Xing M, Lei N, Casiano CA*, and Zhang JY (2016).  Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.  Oncotarget 7:43546-43556. *shared senior authorship      (07/2016)
  • Mahler M, Meroni PL, Andrade LE, Khamashta M, Bizzaro N, Casiano CA, Fritzler MJ (2016) Towards a better understanding of the clinical association of anti-DFS70 autoantibodies. Autoimmunity Reviews 15:198-201.    (02/2016)
  • Basu A, Cajigas-Du Ross C, Rios-Colon L, Daniels T, Leoh LS, Mediavilla-Varela M, Rojas H, Banerjee H, Martinez SR, Acevedo-Martinez S, and Casiano CA (2016). LEDGF/p75 overexpression attenuates oxidative stress-induced necrosis and upregulates ERp57/PDIA3/GRp58 in prostate cancer. PLoS One 11:e0146549.     (01/2016)
  • Basu A, Ortiz G, Burnham LW, Rios-Colon L, Figueroa J, Albesa R, Andrade L, Mahler M, and Casiano CA (2015).  Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2. Clinical Immunology 161:241-250.    (12/2015)
  • Turay D, Khan S, Diaz-Osterman CJ, Curtis MP, Khaira B, Neidigh JW, Mirshahidi S, Casiano CA, and Wall NR (2016) Proteomic profiling of serum-derived exosomes from ethnically diverse prostate cancer patients.  Cancer Investigation34:1-11.    (11/2015)
  • Nicholas DA, Salto LM, Boston AM, Beeson L, Firek A, Casiano CA, Langridge WHR, Cordero-McIntyre, and De Leon M (2015). Identification of anti-palmitic acid IgG autoantibodies in serum of patients with type 2 diabetes.  Mediators of Inflammation 2015:196297   (11/2015)
  • Basu A, Sanchez TW, and Casiano CA (2015) DFS70/LEDGFp75: an enigmatic autoantigen at the interface between autoimmunity, AIDS, and cancer.   Frontiers in Immunology 6:116.     (03/2015)
  • Pacheco FJ, Almaguel FG, Evans W, Leoh LS, Rook-Arena E, Rios-Colon L, Mediavilla-Varela M, Filippov V, De Leon M, and Casiano CA (2014). Docosahexanoic acid antagonizes TNF-a-induced cell death by attenuating oxidative stress, lysosomal dysfunction, autophagy, and ceramide production.  Inflammation Research 63:859-71.    (10/2014)
  • Salto LM, Riggs ML, De Leon DD, Casiano CA, and De Leon M (2014). Early gains in research self-efficacy lead to lasting STEM success for underrepresented minority students: an outcomes comparison between high school and college participants of the Loma Linda University Health Disparities Summer Research Program.  PLoS One 9(9):e108497.    (09/2014)
  • Dai L, Li J, Ortega R, Qian W, Casiano CA, and Zhang JY (2014) Preferential autoimmune response in prostate cancer to Cyclin B1 in a panel of tumor-associated antigens. Journal of Immunology Research, 2014:827827.    (04/2014)
  • Basu A, Drame A, Munoz R, De Leon M, and Casiano CA (2012) Pathway specific gene expression profiling reveals candidate target genes of the stress transcription coactivator LEDGF/p75 in prostate cancer cells. Prostate 72:597-611.      (05/2012)
  • Basu A, Rojas H, Banerjee H, Cabrera I, Perez K, and Casiano CA (2012) Expression of the stress oncoprotein LEDGF/p75 in human cancers: a study of 21 tumor types.  PLoS One  7:e30132.     (01/2012)
  • Fritzler MJ, Rattner JB, Luft LM, Edworthy SM, Casiano CA, Peebles C, and Mahler M (2011).  Historical perspectives on the discovery of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F.  Autoimmunity Reviews 10:194-200.    (02/2011)
  • Basu A, Banerjee H, Rojas H, Martinez SR, Roy S, Jia Z, Lilly MB, De Leon M, and Casiano CA (2011).  Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.  Prostate 71:755-765.         (10/2010)
  • Almaguel FG,  Liu JW,  Pacheco FJ,  De Leon DD,  Casiano CA, and De Leon M (2010).  Lipotoxicity-mediated cell dysfunction and death involves lysosomal membrane permeabilization and cathepsin L activity.   Brain Research 1318:133-43.   (02/2010)

Scholarly Journals--Accepted

  • Woods-Burnham L, Stiel L, Martinez SR, Sanchez-Hernandez ES, Ruckle HC, Almaguel FA, Stern MC, Roberts LR, Williams DR, Montgomery S, and Casiano CA (2020).  Psychosocial stress, glucocorticoid signaling, and prostate cancer health disparities.  Cancer Health Disparities (in press)         (06/2020)

Books and Chapters

  • Ortiz-Hernandez GL, Sanchez-Hernandez ES, Casiano CA (2019). Update on the DFS70 autoantibody/autoantigen system and current challenges in understanding its clinical and biological significance.   In “Precision Medicine: Role of Autoantibodies in the Prediction and Care of Autoimmune Diseases.”  Autoantigens, Autoantibodies, and Autoimmunity, 12:32-44.  PABST Science-Publishers. Conrad K, Andrade LEC, Chan EKL, Fritzler MJ, Prujin GJM, Shoenfeld Y, Steiner G (Eds)       (06/2019 - 09/2019)
  • Sanchez T and Casiano CA (2017) Alpha enolase: novel insights into an old autoantibody-autoantigen system.  In “Immunodeficiency, Infection, and Autoimmune Diseases.”  Autoantigens, Autoantibodies, and Autoimmunity, 11:32-44.  PABST Science-Publishers. Conrad K, Andrade LEC, Chan EKL, Fritzler MJ, Prujin GJM, Shoenfeld Y (Eds)       (07/2017 - 09/2017)
  • Basu A, Rios-Colon L, and Casiano CA (2015) The enigmatic DFS70/LEDGFp75 autoantibody-autoantigen system: from basic biology to clinical applications. In “From Autoantibody Research to Standardized Diagnostic Assays in the Management of Human Diseases”. Autoantigens, Autoantibodies, and Autoimmunity 10:149-158. Ed. Conrad K, Chan EKL, Andrade LEC, Steiner G, Prujin JM, Shoenfeld Y.  PABST Science Publishers, Lengerich, Germany.        (06/2015 - 09/2015)
  • Sanchez TW, Montgomery S, Wilson C, Zhang JY, and Casiano CA (2015). Diagnostic utility of tumor associated autoantigen panels for autoantibody profiling in cancer: recent advances and future directions.   In “From Autoantibody Research to Standardized Diagnostic Assays in the Management of Human Diseases”. Autoantigens, Autoantibodies, and Autoimmunity 10: 43-60. Ed. Conrad K, Chan EKL, Andrade LEC, Steiner G, Prujin JM, Shoenfeld Y.  PABST Science Publishers, Lengerich, Germany.        (06/2015 - 09/2015)
  • Sanchez TW, Basu A, Mirshahidi S, Chen CS, Montgomery S, Wilson C, Zhang JY, Wall N, and Casiano CA (2013). Immunoproteomic profiling in prostate cancer: a health disparities perspective.   In “Infection, Tumors, and Autoimmunity”.  Autoantigens, Autoantibodies, and Autoimmunity 9:46-56.  Ed. Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Meroni PL, Steiner G, Shoenfeld Y.  PABST Science Publishers, Lengerich, Germany.        (06/2013 - 09/2013)
  • Dai L, Ren P, Casiano CA, and Zhang JY (2013).  Autoantibodies to tumor-associated antigens (TAAs) as biomarkers in the immunodiagnosis of cancer. In “Infection, Tumors, and Autoimmunity”.  Autoantigens, Autoantibodies, and Autoimmunity 9:38-45.  Ed. Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Meroni PL, Steiner G, Shoenfeld Y.  PABST Science Publishers, Lengerich, Germany.          (06/2013 - 09/2013)
  • Casiano CA and Pacheco FJ.  (2006) Autoimmunity and Cell Death.  In Autoantibodies and Autoimmunity: Molecular Mechanisms in Health and Disease.  Ed.  Pollard, KM.   WILEY-VCH Verlag GmbH, Weinheim, Germany. pp. 107-137.         (01/2006 - 12/2006)
  • Casiano CA, Molinaro CHolder S, and Wu X (2002).  Distinct cleavage products of nuclear autoantigens in apoptosis and necrosis: implications for autoimmunity. In: Apoptosis and Autoimmunity. Ed. Kalden J, and Herrmann M. WILEY-VCH Verlag GmbH, Weinheim, Germany.  pp. 261-288.       (01/2002 - 12/2002)
  • Casiano CA (2000). Autoantibodies to the proliferation-associated nuclear protein CENP-F in cancer.  In Cancer and Autoimmunity pp 175-180. Eds. Shoenfeld Y and Gershwin ME. Elsevier Science publishers. (01/2000 - 12/2000)
  • Casiano CA and Tan EM (1998). Apoptosis, autoantigens, and autoimmunity. In The Autoimmune Diseases.   Ed.  Rose, N. and Mackay, I.  Academic Press, San Diego. pp. 193-210.  (01/1998 - 12/1998)